Have been sitting on this for a few days and am now really excited to share *4* papers just published online today in @CD_AACR, with variations on the theme of cancer cell #plasticity as a mechanism of resistance to #KRAS inhibition https://t.co/mVeoSPYot5 (🧵)

Updated @NCCN guidelines (1.2025) are in, with some major changes for systemic therapies: 1) Ipi+Nivo is now a preferred regimen in fav-risk ccRCC 2) Len+Pem/Cabo+Nivo are now preferred regimens for non-clear cell RCC 3) Adjuvant Pembro is now Category 1 @kidneycan

Well it’s official…my time at @CD_AACR has come to end and I start a new chapter as an Oncology Scientist/Medical Writer at @NCCN. It was such a pleasure to work to promote high impact cancer research but I am excited to shift and work on the clinical oncology guidelines!

Read the paper featured on this month's cover: #Sotorasib Is a pan-RAS G12C Inhibitor Capable of Driving Clinical Response in NRAS G12C cancers, by @Labrat3, Noritaka Tanaka, @andrewaguirremd, Ryan Corcoran et al. https://t.co/Vn1S3624tk @DanaFarber @MGHCancerCenter #KRAS

I spend a lot of time outside—walking my dog, hiking—you name it. Wearing sunscreen or protective clothing is a regular part of my routine. Protecting your skin from UV radiation isn't just for #MelanomaMonday, it's an everyday essential! ☀️ https://t.co/272kwR96LE #SkinCancer

Congratulations to Bell and Yi on back to back @CD_AACR papers. Go @sastewartlab and @SitemanCenter https://t.co/9xsnydtLCK

Turns our MyCAFs become Senescent (SenCAFs) and can drive both breast and pancreas cancer progression through immune modulation. See just now online at Cancer Discovery https://t.co/fpbezZOKfe https://t.co/9xsnydtLCK

Check it out-the world of CAFs is more complex-senescent CAFs (senCAFs) drive breast cancer progression by inhibiting NK cells @CD_ AACR. https://t.co/FG2szr6rpI

And senCAFs are differ in the pancreas! Yup, tissues ARE different. @CD_AARC wotj @DeNardoLabWUSM https://t.co/TfY4b7VVXi

Now online in @CD_AACR: back-to-back papers from the labs of @sastewartlab and @DeNardoLabWUSM on immunosuppression by senescent CAFs in breast and pancreatic cancers https://t.co/fM7ac7UHNp https://t.co/mtmOoZfUiN @jennifer_jiayu @JadBelle #DevashishSen @WUSTLmed @SitemanCenter

In @CAPR_AACR from @hopkinskimmel & @MDAndersonNews #PancreaticCancer teams: Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors https://t.co/PPLsGC8wT4 In an unselected population, 1 in 5 harbor germline alterations

From San Diego #AACR2024 to the Colosseum in Rome. I had the best time presenting our @CD_AACR research @istsupsan. Engaged in insightful discussions about DNA repair and genome stability with @PietroPichierri and Annapaola Franchitto! #GenomeStability #DNARepair

Thanks to 23K participants & @AACR colleagues for a great #AACR24. It was a diverse, multidimensional, concentrated extract of global cancer research. Next step: turning presentations to publications! Happy to help with that at @BCD_AACR.

A Vision for Democratizing Next-Generation Oncology Clinical Trials [Apr 4, 2024] @VivekSubbiah Horgan @IshwariaMD @CD_AACR https://t.co/SfNBMrCivh #PrecisionMedicine #ClinicalTrials #ctsm

Even though #AACR24 has come to an end, you can continue the celebration by viewing the @CD_AACR April issue full of special commentaries including this one by our fearless Editors-in-Chief @CantleyLab and @ldiaz1971 https://t.co/vKybRoIimj

Thank you to @AACR, @AmericanCancer, and @CRC_AACR for supporting our work from the @DamaniaLab at @UNC_Lineberger ! I had a great time at #AACR24 and meeting all the wonderful people involved in these organizations @ACS_Research @ACSNews #lymphoma #CancerResearch

Such a delight to meet with the terrific Arul Chinnayan at @AACR - @VivekSubbiah #AACR24 #AACR #Cancer #CancerResearch #OncoDaily #Oncology #SarahCannonResearchInstitute https://t.co/56S8gnkvuu

The closing plenary is over, and so is #AACR24. We thank Program Chairs Keith T. Flaherty and Christina Curtis and the entire Program Committee for developing an inspiring meeting, and we look forward to seeing everyone in Chicago for #AACR25.

Wonderful to see our #liquidbiopsies research highlighted in the #AACR24 #precisiononcology special series! Read the open access @CCR_AACR study: https://t.co/AlcnCuRKEy @AACR @HopkinsThoracic @HopkinsMedicine @LavanyaSivapal1 @josephcmurray

If you enjoyed the session on the Tumor Microbiome at #AACR24, be sure to read this recent Convergence Science paper on the relationship between stress and bacteria in #coloncancer. https://t.co/0nYW1rtyHV